SGRY · Surgery Partners, Inc. · Documents

Nov 8

Quarterly report 10-Q FY2022 Q3, ended Sep 30

Quarterly report for FY2022 Q3

Revenue $620.6M ▲ 11.0% Net loss $25M Diluted EPS -$0.28

Aug 2

Earnings call

Q2 2022 earnings call

Aug 2

Current report 8-K

Financial results

Aug 2

Quarterly report 10-Q FY2022 Q2, ended Jun 30

Quarterly report for FY2022 Q2

Revenue $615.4M ▲ 13.3% Net loss $18.4M Diluted EPS -$0.21

May 20

Current report 8-K Events of May 19

Shareholder vote results

May 3

Earnings call

Q1 2022 earnings call

May 3

Current report 8-K

Financial results

May 3

Quarterly report 10-Q FY2022 Q1, ended Mar 31

Quarterly report for FY2022 Q1

Revenue $596.2M ▲ 16.4% Net income $12.2M Diluted EPS $0.14

Apr 7

Proxy statement DEF 14A Meeting May 19, 2022

Proxy statement

Apr 7

Proxy statement DEFA14A

Proxy statement

Mar 1

Annual report 10-K FY2021, ended Dec 31

Annual report for FY2021

Revenue $2.23B ▲ 19.6% Net loss $70.9M Diluted EPS -$1.12

Feb 28

Earnings call

Q4 2021 earnings call

Feb 28

Current report 8-K

Financial results

Jan 10

Current report 8-K Events of Jan 5

Financial results, Director or officer change, or executive pay

Nov 22

Current report 8-K Events of Nov 19

Entered into a material agreement, New debt or off-balance-sheet obligation

Nov 9

Current report 8-K Events of Nov 8

Entered into a material agreement

Nov 3

Quarterly report 10-Q FY2021 Q3, ended Sep 30

Quarterly report for FY2021 Q3

Revenue $559.2M ▲ 12.7% Net loss $22.9M Diluted EPS -$0.28

Nov 2

Earnings call

Q3 2021 earnings call

Nov 2

Current report 8-K

Financial results

Aug 17

Current report 8-K

Regulation FD disclosure

Aug 4

Earnings call

Q2 2021 earnings call

Aug 4

Current report 8-K

Financial results

Aug 4

Quarterly report 10-Q FY2021 Q2, ended Jun 30

Quarterly report for FY2021 Q2

Revenue $543.3M ▲ 45.0% Net loss $26.9M Diluted EPS -$0.39

May 28

Current report 8-K Events of May 26

Director or officer change, or executive pay, Shareholder vote results

May 18

Current report 8-K Events of May 17

Unregistered sale of equity

May 5

Current report 8-K Events of May 3

Entered into a material agreement, New debt or off-balance-sheet obligation

May 5

Current report 8-K

Financial results

May 5

Quarterly report 10-Q FY2021 Q1, ended Mar 31

Quarterly report for FY2021 Q1

Revenue $512.4M ▲ 16.2% Net loss $21M Diluted EPS -$0.57

Apr 20

Earnings call

Q1 2021 earnings call

Apr 20

Current report 8-K

Financial results, Regulation FD disclosure, Other events

Apr 15

Proxy statement DEF 14A Meeting May 26, 2021

Proxy statement

Apr 15

Proxy statement DEFA14A

Proxy statement

Mar 10

Current report 8-K

Financial results

Mar 10

Annual report 10-K FY2020, ended Dec 31

Annual report for FY2020

Revenue $1.86B ▲ 1.6% Net loss $116.1M

Mar 2

Current report 8-K Events of Feb 24

Director or officer change, or executive pay

Jan 29

Current report 8-K Events of Jan 27

Entered into a material agreement, New debt or off-balance-sheet obligation

Jan 25

Registration statement S-3ASR

Registration statement

Jan 11

Earnings call

Q4 2020 earnings call

Jan 11

Current report 8-K

Financial results

Nov 4

Earnings call

Q3 2020 earnings call

Nov 4

Current report 8-K

Financial results

Nov 4

Quarterly report 10-Q FY2020 Q3, ended Sep 30

Quarterly report for FY2020 Q3

Revenue $496.1M ▲ 9.8% Net loss $61.6M Diluted EPS -$1.46

Aug 5

Current report 8-K

Financial results

Aug 5

Quarterly report 10-Q FY2020 Q2, ended Jun 30

Quarterly report for FY2020 Q2

Revenue $374.7M ▼ 15.9% Net loss $32.5M Diluted EPS -$0.86

Jul 31

Current report 8-K Events of Jul 30

Entered into a material agreement, New debt or off-balance-sheet obligation

Jul 24

Current report 8-K Events of Jul 23

Other events

Jul 22

Earnings call

Q2 2020 earnings call

Jul 22

Current report 8-K

Financial results, Regulation FD disclosure

May 28

Current report 8-K Events of May 27

Shareholder vote results

May 11

Earnings call

Q1 2020 earnings call